Viewpoint

Traditional innovation has been about creating something new that an individual can pay for. That’s no longer enough, says Mats Williander.

The UK already has a world-class science base. The more pressing challenge is how to stay in the premier league.

Why do so many European inventions get lost in the move from lab to market? Science|Business suggests 9 simple ways that European leaders could fix that problem – for the benefit of Europe’s economy.

Finding the magic ingredients that will generate innovation remains a major preoccupation across the public and private sectors. Two leading protagonists from academe and industry shares their thoughts.

This week, Science|Business launches an initiative to improve the process of innovation in Europe – an online marketplace to link scientists and industry.

Are our politicians really using science to make the best decisions? Or are they just hiding behind science, rather than using their common sense?

Asian R&D is hot. Witness our summertime sampling of news tidbits – some important, some just bizarre.

Biotech start-ups in France and elsewhere in Europe make a unique and important contribution to healthcare. They merit special treatment to help them grow.

The stock-market debut at the end of July of Imperial College London’s tech-transfer office is the best news for academic reform in years.

Complying with the EU’s labyrinthine new REACH chemicals legislation was always going to be a tortuous process. For those who wait too long, it could be impossible.